There is a high incidence and mortality rate of Hodgkin’s cancer worldwide. In India, the 5-year overall event-free survival and overall survivals were 77.75% and 92.7%, respectively. The standardized worldwide rates of Hodgkin’s lymphoma and mortality in 2012 were 0.9 and 0.3 per 100,000, respectively.
Five-year survival reflects the proportion of patients who survived more than five years after treatment for Hodgkin’s lymphoma, based on the stage of the disease at the time of diagnosis. Many of these patients live for more than five years. While the survival rate for Stage I is 90%-95%. For Stage II is 90%-95%, Stage III is 85%-90% and Stage IV is about 65%
Even so, the treatment for Hodgkin’s lymphoma can lead to long-term health problems, including leukemia, breast cancer, myelodysplastic syndrome, heart disease, lung disease, thyroid disease, and infertility. Therefore, patients treated for Hodgkin’s lymphoma must undergo an annual physical examination, as they may require screening for other diseases. Hence, patients should seek medical attention for any new, serious, or unexplained symptoms that don’t go away1.
The survival rate of Hodgkin’s Lymphoma in India
According to Trehan et al., India’s 5-year overall survival and event-free survival rates were 92.7% and 77.75%, respectively. Children with early-stage disease and absence of B symptoms had a better overall survival of 97.7% each, compared with 87.2% and 88.2% in those with late-stage disease and B symptoms, respectively2.
Global incidence and mortality rate of Hodgkin’s Lymphoma
Consequently, the standardized worldwide rates of Hodgkin’s lymphoma and mortality in 2012 were 0.9 and 0.3 per 100,000, respectively. However, a significant positive association was reported between the standardized incidence rate of Hodgkin lymphoma and the human development index (HDI)3.
- 1.Understanding Hodgkin Lymphoma — Diagnosis and Treatment. WebMD. Published 2022. Accessed March 2022. https://www.webmd.com/cancer/lymphoma/understanding-hodgkins-disease-treatment
- 2.Trehan A, Singla S, Marwaha RK, Bansal D, Srinivasan R. Hodgkin Lymphoma in Children. Journal of Pediatric Hematology/Oncology. Published online April 2013:174-179. doi:10.1097/mph.0b013e318271f587
- 3.Khodamoradi F, Pakzad R, Ghoncheh M, Gandomani HS, Salehiniya H. Еpidemiology, incidence and mortality of Hodgkin’s cancer in the world and its relation with development. WCRJ. 2018;5(2).